Optimal doses of caspofungin during continuous venovenous hemodiafiltration in critically ill patients

被引：11
|
作者：
Aguilar, Gerardo [1 ]
Ferriols, Rafael [2 ]
Lozano, Angels [1 ]
Ezquer, Carlos [3 ]
Carbonell, Jose A. [1 ]
Jurado, Ana [1 ]
Carrizo, Juan [1 ]
Serralta, Ferran [1 ]
Puig, Jaume [1 ]
Navarro, David [4 ,5 ]
Alos, Manuel [2 ]
Javier Belda, F. [1 ,5 ]
机构：
[1] Univ Valencia, Hosp Clin, Surg Intens Care Unit, Dept Anesthesiol & Intens Care, Ave Blasco Ibanez 17, Valencia 46010, Spain
[2] Univ Valencia, Hosp Clin, Dept Pharm, Ave Blasco Ibanez 17, Valencia 46010, Spain
[3] INCLIVA, Inst Invest Sanitaria, Ave Blasco Ibanez 17, Valencia 46010, Spain
[4] Univ Valencia, Hosp Clin, Dept Microbiol, Ave Blasco Ibanez 17, Valencia 46010, Spain
[5] Univ Valencia, Sch Med, Ave Blasco Ibanez 17, Valencia 46010, Spain
来源：
CRITICAL CARE | 2017年 / 21卷
关键词：
Echinocandins; Continuous renal replacement therapy; Invasive candidiasis; RENAL REPLACEMENT THERAPY; PHARMACOKINETICS;
D O I：
10.1186/s13054-016-1594-9
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [1] Optimal doses of caspofungin during continuous venovenous hemodiafiltration in critically ill patients
    Gerardo Aguilar
    Rafael Ferriols
    Angels Lozano
    Carlos Ezquer
    José A. Carbonell
    Ana Jurado
    Juan Carrizo
    Ferran Serralta
    Jaume Puig
    David Navarro
    Manuel Alos
    F. Javier Belda
    Critical Care, 21
  • [2] Pharmacokinetics of levofloxacin during continuous venovenous hemodiafiltration and continuous venovenous hemofiltration in critically ill patients
    Guenter, SG
    Iven, H
    Boos, C
    Bruch, HP
    Muhl, E
    PHARMACOTHERAPY, 2002, 22 (02): : 175 - 183
  • [3] Pharmacokinetics of Ganciclovir during Continuous Venovenous Hemodiafiltration in Critically Ill Patients
    Horvatits, Thomas
    Kitzberger, Reinhard
    Drolz, Andreas
    Zauner, Christian
    Jaeger, Walter
    Boehmdorfer, Michaela
    Kraff, Stefanie
    Fritsch, Achim
    Thalhammer, Florian
    Fuhrmann, Valentin
    Schenk, Peter
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2014, 58 (01) : 94 - 101
  • [4] Pharmacokinetics and dosage adaptation of meropenem during continuous venovenous hemodiafiltration in critically ill patients
    Robatel, C
    Decosterd, LA
    Biollaz, J
    Eckert, P
    Schaller, MD
    Buclin, J
    JOURNAL OF CLINICAL PHARMACOLOGY, 2003, 43 (12): : 1329 - 1340
  • [5] Measurement and calculation of the extracorporeal elimination of vancomycin during continuous venovenous hemodiafiltration and continuous venovenous hemofiltration in critically ill patients
    Muhl, E
    Bundesen, J
    Iven, H
    Bruch, HP
    JOURNAL OF INTENSIVE CARE MEDICINE, 2001, 16 (05) : 222 - 230
  • [6] Continuous venovenous hemodiafiltration with citrate anticoagulant in critically ill pediatric patients
    Powel, V
    Peterson, B
    Griswold, W
    CRITICAL CARE MEDICINE, 1999, 27 (01) : A61 - A61
  • [7] A PROSPECTIVE COMPARATIVE-STUDY OF CONTINUOUS ARTERIOVENOUS HEMODIAFILTRATION AND CONTINUOUS VENOVENOUS HEMODIAFILTRATION IN CRITICALLY ILL PATIENTS
    BELLOMO, R
    PARKIN, G
    LOVE, J
    BOYCE, N
    AMERICAN JOURNAL OF KIDNEY DISEASES, 1993, 21 (04) : 400 - 404
  • [8] Pharmacokinetics and drug dosing adjustments during continuous venovenous hemofiltration or hemodiafiltration in critically ill patients
    Bugge, JF
    ACTA ANAESTHESIOLOGICA SCANDINAVICA, 2001, 45 (08) : 929 - 934
  • [9] Optimizing ceftolozane-tazobactam dosage in critically ill patients during continuous venovenous hemodiafiltration
    Gerardo Aguilar
    Rafael Ferriols
    Sara Martínez-Castro
    Carlos Ezquer
    Ernesto Pastor
    José A. Carbonell
    Manuel Alós
    David Navarro
    Critical Care, 23
  • [10] Copper, selenium, zinc, and thiamine balances during continuous venovenous hemodiafiltration in critically ill patients
    Berger, MM
    Shenkin, A
    Revelly, JP
    Roberts, E
    Cayeux, MC
    Baines, M
    Chioléro, RL
    AMERICAN JOURNAL OF CLINICAL NUTRITION, 2004, 80 (02): : 410 - 416
12345